These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 37814809)

  • 1. Design, synthesis, and biological activity evaluation of new tankyrase-2 directed inhibitors.
    Zhang X; Pang W; Li T; Lin T; Yuan J; Xu S
    Chem Biol Drug Des; 2024 Jan; 103(1):e14360. PubMed ID: 37814809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and biological evaluation of isoquinolin-1(2
    Yao H; Wang Y; Jiangwen M; Peng Y; Wang Z
    Pharmazie; 2021 Apr; 76(4):132-137. PubMed ID: 33849696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New molecular insights for 4
    Mehta CC; Rohit S; Patel S; Bhatt HG
    J Biomol Struct Dyn; 2023; 41(22):13496-13508. PubMed ID: 36755438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular insights on TNKS1/TNKS2 and inhibitor-IWR1 interactions.
    Kirubakaran P; Kothandan G; Cho SJ; Muthusamy K
    Mol Biosyst; 2014 Feb; 10(2):281-93. PubMed ID: 24291818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-Phenylquinazolinones as dual-activity tankyrase-kinase inhibitors.
    Nkizinkiko Y; Desantis J; Koivunen J; Haikarainen T; Murthy S; Sancineto L; Massari S; Ianni F; Obaji E; Loza MI; Pihlajaniemi T; Brea J; Tabarrini O; Lehtiö L
    Sci Rep; 2018 Jan; 8(1):1680. PubMed ID: 29374194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the Effects of Chirality of 5-methyl-5-[4-(4-oxo-3H-quinazolin-2-yl) phenyl]imidazolidine-2,4-dione and its Derivatives on the Oncological Target Tankyrase 2. Atomistic Insights.
    Quintina Peters X; Poonan P; Salifu Yakubu E; Issa Alahmdi M; Abo-Dya NE; Soliman M
    Curr Pharm Biotechnol; 2023 Mar; ():. PubMed ID: 37005548
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Loganathan L; Muthusamy K; Jayaraj JM; Kajamaideen A; Balthasar JJ
    J Biomol Struct Dyn; 2019 Sep; 37(14):3637-3648. PubMed ID: 30204055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of potent and selective nonplanar tankyrase inhibiting nicotinamide mimics.
    Nkizinkiko Y; Suneel Kumar BVS; Jeankumar VU; Haikarainen T; Koivunen J; Madhuri C; Yogeeswari P; Venkannagari H; Obaji E; Pihlajaniemi T; Sriram D; Lehtiö L
    Bioorg Med Chem; 2015 Aug; 23(15):4139-4149. PubMed ID: 26183543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis and SAR for G007-LK, a lead stage 1,2,4-triazole based specific tankyrase 1/2 inhibitor.
    Voronkov A; Holsworth DD; Waaler J; Wilson SR; Ekblad B; Perdreau-Dahl H; Dinh H; Drewes G; Hopf C; Morth JP; Krauss S
    J Med Chem; 2013 Apr; 56(7):3012-23. PubMed ID: 23473363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of Novel Tankyrase Inhibitors through Molecular Docking-Based Virtual Screening and Molecular Dynamics Simulation Studies.
    Berishvili VP; Kuimov AN; Voronkov AE; Radchenko EV; Kumar P; Choonara YE; Pillay V; Kamal A; Palyulin VA
    Molecules; 2020 Jul; 25(14):. PubMed ID: 32664504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of new dual binding TNKS inhibitors of Wnt signaling inhibition by pharmacophore modeling, molecular docking and bioassay.
    Pu Y; Zhang S; Chang Z; Zhang Y; Wang D; Zhang L; Li Y; Zuo Z
    Mol Biosyst; 2017 Jan; 13(2):363-370. PubMed ID: 27995250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of Novel Spiroindoline Derivatives as Selective Tankyrase Inhibitors.
    Shirai F; Tsumura T; Yashiroda Y; Yuki H; Niwa H; Sato S; Chikada T; Koda Y; Washizuka K; Yoshimoto N; Abe M; Onuki T; Mazaki Y; Hirama C; Fukami T; Watanabe H; Honma T; Umehara T; Shirouzu M; Okue M; Kano Y; Watanabe T; Kitamura K; Shitara E; Muramatsu Y; Yoshida H; Mizutani A; Seimiya H; Yoshida M; Koyama H
    J Med Chem; 2019 Apr; 62(7):3407-3427. PubMed ID: 30883102
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Liu J; Feng K; Ren Y
    J Biomol Struct Dyn; 2019 Sep; 37(14):3803-3821. PubMed ID: 30261821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel binding mode of a potent and selective tankyrase inhibitor.
    Gunaydin H; Gu Y; Huang X
    PLoS One; 2012; 7(3):e33740. PubMed ID: 22438990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis for the interaction between tankyrase-2 and a potent Wnt-signaling inhibitor.
    Karlberg T; Markova N; Johansson I; Hammarström M; Schütz P; Weigelt J; Schüler H
    J Med Chem; 2010 Jul; 53(14):5352-5. PubMed ID: 20565110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploration of the nicotinamide-binding site of the tankyrases, identifying 3-arylisoquinolin-1-ones as potent and selective inhibitors in vitro.
    Paine HA; Nathubhai A; Woon EC; Sunderland PT; Wood PJ; Mahon MF; Lloyd MD; Thompson AS; Haikarainen T; Narwal M; Lehtiö L; Threadgill MD
    Bioorg Med Chem; 2015 Sep; 23(17):5891-908. PubMed ID: 26189030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of tankyrase activity by a catalytic domain dimer interface.
    Fan C; Yarravarapu N; Chen H; Kulak O; Dasari P; Herbert J; Yamaguchi K; Lum L; Zhang X
    Biochem Biophys Res Commun; 2018 Sep; 503(3):1780-1785. PubMed ID: 30055800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening and structural analysis of flavones inhibiting tankyrases.
    Narwal M; Haikarainen T; Fallarero A; Vuorela PM; Lehtiö L
    J Med Chem; 2013 May; 56(9):3507-17. PubMed ID: 23574272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis and selectivity of tankyrase inhibition by a Wnt signaling inhibitor WIKI4.
    Haikarainen T; Venkannagari H; Narwal M; Obaji E; Lee HW; Nkizinkiko Y; Lehtiö L
    PLoS One; 2013; 8(6):e65404. PubMed ID: 23762361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic Analysis of the Human Tankyrase Protein Interaction Network Reveals Its Role in Pexophagy.
    Li X; Han H; Zhou MT; Yang B; Ta AP; Li N; Chen J; Wang W
    Cell Rep; 2017 Jul; 20(3):737-749. PubMed ID: 28723574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.